PRQR · ISSUER CIK 1612940
ProQR Therapeutics N.V.
Between Aug 1, 2026 and Oct 29, 2026, 1 ProQR Therapeutics N.V. insiders reported $354K of open-market purchases and $0.00 of sales on SEC Form 4. The largest buyer was de Boer Daniel Anton (Chief Executive Officer, Director), with $354K.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$354KInsider buying
$0.00Insider selling
+$354KNet open-market
Aug 3, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 3, 202616:01 | Jul 31, 2026 | PRQR | Chief Executive Officer, Director | P · Buy | $1.77 | +200,000 | 500,000 | +67% | +$354K | -6.4% | -18.6% |